The long-term objective of this study is to supplant the bone marrow- derived suppressor cells in tumor bearers with tumoricidal macrophages so as to achieve immunological tumor rejection. This will be accomplished in mice bearing cloned metastatic Lewis lung carcinoma (LLC-C3) tumors with myeloid differentiation therapy to drive suppressor cell maturation into nonsuppressive tumoricidal monocytes. The differentiation therapy will be comprised of low doses of recombinant murine interferon-gamma (IFN-gamma) plus recombinant human tumor necrosis factor-alpha (TNF). The rationale for this treatment is based on studies showing that LLC-C3 tumors stimulate myelopoiesis leading to the appearance of immature monocytic suppressor cells and that IFN-gamma and TNF synergize to induce maturation of immature myeloid cells into mature tumoricidal monocytes. Initially, the bone marrow-derived suppressor cells in the bone marrow, spleen, blood and tumor mass of LLC-C3-bearing mice will be driven to mature into nonsuppressive tumoricidal monocytes using myeloid differentiation therapy. Successful elimination of suppressor cells by myeloid differentiation therapy will be evidenced both in vitro by deletion of cells which phenotypically and functionally resemble suppressor cells and in vivo by elimination of tumor growth-promoting activity from cells adoptively transferred together with LLC-C3 tumor cells into recipient mice. Finally, the myeloid differentiation therapy will be used to reduce LLC-C3 tumor progression and to prolong host survival. As a result of this study, a novel therapeutic approach will be identified for replacing suppressor cells in tumor bearers with activated macrophages having the ability to kill tumor. This therapeutic approach to drive differentiation of bone marrow-derived suppressor cells into mature cytolytic monocytes will augment anti-tumor defenses and inhibit tumor progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA048080-02
Application #
3192044
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1990-08-06
Project End
1993-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Loyola University Chicago
Department
Type
Schools of Medicine
DUNS #
791277940
City
Maywood
State
IL
Country
United States
Zip Code
60153
Wiers, K M; Lathers, D M; Wright, M A et al. (2000) Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy. J Immunother 23:115-24
Pandit, R; Lathers, D M; Beal, N M et al. (2000) CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer. Ann Otol Rhinol Laryngol 109:749-54
Lathers, D M; Lubbers, E; Wright, M A et al. (1999) Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients. J Leukoc Biol 65:623-8
Gabel, S; Benefield, J; Meisinger, J et al. (1999) Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngol Head Neck Surg 121:463-8
Young, M R; Lathers, D M (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21:241-52
Lathers, D M; Lubbers, E; Beal, N M et al. (1999) Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different. Hum Immunol 60:1207-15
Wright, M A; Wiers, K; Vellody, K et al. (1998) Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors. Cancer Immunol Immunother 46:253-60
Wiers, K; Wright, M A; Vellody, K et al. (1998) Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels. Clin Exp Metastasis 16:275-82
Young, M R; Wright, M A; Lozano, Y et al. (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer 74:69-74
Garrity, T; Pandit, R; Wright, M A et al. (1997) Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 73:663-9

Showing the most recent 10 out of 50 publications